Antioxidant and neuroprotective effects of caffeine against Alzheimer's and Parkinson's disease: insight into the role of Nrf-2 and A2AR signaling

Ikram, M., Park, T. J., Ali, T. and Kim, M. O. (2020) Antioxidant and neuroprotective effects of caffeine against Alzheimer's and Parkinson's disease: insight into the role of Nrf-2 and A2AR signaling. Antioxidants, 9(9), 902. (doi: 10.3390/antiox9090902) (PMID:32971922) (PMCID:PMC7554764)

Abstract

This paper reviews the results of studies conducted on the role of caffeine in the management of different neurological disorders, such as Parkinson's disease (PD) and Alzheimer's disease (AD). To highlight the potential role of caffeine in managing different neurodegenerative diseases, we identified studies by searching PubMed, Web of Science, and Google Scholar by scrutinizing the lists of pertinent publications. According to the collected overall findings, caffeine may reduce the elevated oxidative stress; inhibit the activation of adenosine A2A, thereby regulating the accumulation of Aβ; reduce the hyperphosphorylation of tau; and reduce the accumulation of misfolded proteins, such as α-synuclein, in Alzheimer's and Parkinson's diseases. The studies have suggested that caffeine has promising protective effects against different neurodegenerative diseases and that these effects may be used to tackle the neurological diseases and/or their consequences. Here, we review the ongoing research on the role of caffeine in the management of different neurodegenerative disorders, focusing on AD and PD. The current findings suggest that caffeine produces potent antioxidant, inflammatory, and anti-apoptotic effects against different models of neurodegenerative disease, including AD, PD, and other neurodegenerative disorders. Caffeine has shown strong antagonistic effects against the adenosine A2A receptor, which is a microglial receptor, and strong agonistic effects against nuclear-related factor-2 (Nrf-2), thereby regulating the cellular homeostasis at the brain by reducing oxidative stress, neuroinflammation, regulating the accumulation of α-synuclein in PD and tau hyperphosphorylation, amyloidogenesis, and synaptic deficits in AD, which are the cardinal features of these neurodegenerative diseases.

• Item Type: Articles
• Additional Information: This research was supported by the Neurological Disorder Research Program of the National Research Foundation (NRF) funded by the Korean Government (MSIT) (2020M3E5D9080660).
• Keywords: Caffeine, antioxidant effects, neurodegeneration, Alzheimer’s disease, Parkinson’s disease, neuroprotective effects.
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Park, Tae Ju
• Authors: Ikram, M., Park, T. J., Ali, T., and Kim, M. O.
• College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
• Journal Name: Antioxidants
• Publisher: MDPI
• ISSN: 2076-3921
• ISSN (Online): 2076-3921
• Published Online: 22 September 2020
• Copyright Holders: Copyright © 2020 The Authors
• First Published: First published in Antioxidants 9(9): 902
• Publisher Policy: Reproduced under a Creative Commons License